Cyclooxygenase-2 expression in the endometrium and its relationship to bleeding in users of continuous oral contraceptives

Gynecological Endocrinology

Volumn 22, Issue 2, 2006, Pages 96-100

  Maia Jr , Hugo ^a   Correia, Tânia ^b   Freitas, Luis ^c   Athayde, Célia ^a   Coutinho, Elsimar M ^a  

^a Centro De Pesquisa E Assistencia Em Reproducao Humana   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Continuous oral contraception; Cyclooxygenase 2; Endometrial bleeding

Indexed keywords

CYCLOOXYGENASE 2; EOSIN; ETHINYLESTRADIOL PLUS GESTODENE; GESTINOL; HEMATOXYLIN; KI 67 ANTIGEN; ORAL CONTRACEPTIVE AGENT; PROSTAGLANDIN; PROTEIN BCL 2;

ADULT; AMENORRHEA; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; ENDOMETRIUM; ENDOMETRIUM ABLATION; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS BLEEDING;

ADULT; CONTRACEPTIVES, ORAL; CYCLOOXYGENASE 2; ENDOMETRIUM; EPITHELIUM; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; UTERINE HEMORRHAGE;

EID: 33645765792     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600585724     Document Type: Article

References (19)

1. Rhoton-Vlasak A, Chegini N, Hardt N, Williams RS. Histological characteristics and altered expression of interleukin (IL) IL-13 and 15 in endometria of levonorgestrel users with different uterine bleeding patterns. Fertil Steril 2005;83:659-665.
2. Kelly RW, King AE, Critchley HO. Cytokine control in human endometrium. Reproduction 2001;121:3-19.
3. Chegini N, Ma C Roberts M, Williams RS, Ripps BA. Differential expression of interleukins (IL) IL-13 and IL 15 throughout the menstrual cycle in endometrium of normal fertile women and in women with recurrent spontaneous abortion. J Reprod Immunol 2002;56:93-110.
4. Dunn CL, Critchley HO, Kelly RW. IL-15 regulation in human endometrial stroma cells. J Clin Endocrinol Metab 2002;87:1898-1901.
5. Okada H, Nakajima T, Sanezumi M, Ikuta A, Yasuda K, Kanzaki H. Progesterone enhances interleukin-15 production in human endometrial stroma cells in vitro. J Clin Endocrinol Metab 2000;85:4765-4770.
6. Min SY, Hwang SY, Jung YO, Jeong J, Park SH, Cho CS, Kim HY, Kim WU. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes. J Rheumatol 2004;31:875-883.
7. Coll Capdevilla C. Dysfunctional uterine bleeding and dysmenorrhea. Eur J Contracept Reprod Health Care 1997;2:229-237.
8. Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981;88:434-442.
9. Hickey M, Fraser IS. Clinical implications of disturbances of uterine morphology and function. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:937-951.
10. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamysalate, mefenamic acid and tranexamic acid. Br Med J 1996;313:579-582.
11. Schrager S. Abnormal uterine bleeding associated with hormonal contraception. Am Fam Physician 2002;65:2073-2080.
12. Shaamash AH, Zakhari MM. Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants: a possible role in progestin-induced bleeding. Hum Reprod 2005;20:302-306.
13. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 2005;57:217-252.
14. Li W, Xu RJ, Jiang LH, Shi J, Long X, Fan B. Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma. Med Oncol 2005;22:63-70.
15. Kaewrudee S, Taneepanichskul S, Jaisamraun U, Reinprayoon D. The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use. Contraception 1999;60:25-30.
16. Kelly RW, Smith SK. Progesterone and antiprogestins, a comparison of their effect on prostaglandin production by human secretory phase endometrium and decidua. Prostaglandins Leukot Med 1987;29:181-186.
17. Critchley HO, Kelly RW, Brenner RM, Baird DT. Antiprogestins as a model for progesterone withdrawal. Steroids 2003;68:1061-1068.
18. Charnock-Jones DS, Macpherson AM, Archer DF, Leslie S, Makkink WH, Sharkey AM, Smith SK. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 2000;15(Suppl 3): 85-95.
19. Gallo MF, Nanda K, Grimes DA, Schulz KF. Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials. Contraception 2005;71:162-169.